AbbVie sees hit to Humira sales from European competition

U.S. drugmaker AbbVie Inc on Friday lowered its forecast for overseas sales of its top-selling medicine, Humira, due to larger-than-expected pricing cuts because of new competition in Europe.

Source: Business

Leave a Reply

Your email address will not be published. Required fields are marked *

eighteen − 17 =